Welcome! You are visiting the MyeloRx web site.

Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
Natural Products
 
Molecular Targets
NF-κB
PI3-Kinase
Hsp70
 
Functionally similar to rapamycin and paclitaxol in that the natural products have potent anti-cancer and immune suppressant properties but with a different mechanism of action